SEARCH

SEARCH BY CITATION

References

  • 1
    Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732737.
  • 2
    Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178185.DOI: 10.1034/j.1600-6143.2003.00010.x
  • 3
    Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplant 1989; 47: 278281.
  • 4
    Miles AM, Sumrani N, Horowitz R et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplant 1998; 65: 380384.DOI: 10.1097/00007890-199802150-00014
  • 5
    Friedman EA, Shyh TP, Beyer MM, Manis T, Butt KM. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985; 5: 196202.
  • 6
    Boudreaux JP, McHugh L, Canafax DM et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplant 1987; 44: 376381.
  • 7
    Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001; 15: 8994.DOI: 10.1034/j.1399-0012.2001.150202.x
  • 8
    Matas AJ, Humar A, Gillingham KJ et al. Five preventable causes of kidney graft loss in the 1990s: A single-center analysis. Kidney Int 2002; 62: 704714.DOI: 10.1046/j.1523-1755.2002.00491.x
  • 9
    Sumrani N, Delaney V, Ding Z et al. Posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplant Proc 1991; 23: 12491250.
  • 10
    Hathaway DK, Tolley EA, Blakely ML, Winsett RP, Gaber AO. Development of an index to predict posttransplant diabetes mellitus. Clin Transplant 1993; 7: 330338.
  • 11
    Hjelmesaeth J, Hartmann A, Kofstad J et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplant 1997; 64: 979983.DOI: 10.1097/00007890-199710150-00008
  • 12
    Jawad F, Rizvi SA. Posttransplant diabetes mellitus in live-related renal transplantation. Transplant Proc 2000; 32: 1888.DOI: 10.1016/S0041-1345(00)01478-0
  • 13
    Von Kiparski A, Frei D, Uhlschmid G, Largiader F, Binswanger U. Post-transplant diabetes mellitus in renal allograft recipients: a matched-pair control study. Nephrol Dial Transplant 1990; 5: 220225.
  • 14
    Rao M, Jacob CK, Shastry JC. Post-renal transplant diabetes mellitus–a retrospective study. Nephrol Dial Transplant 1992; 7: 10391042.
  • 15
    Vesco L, Busson M, Bedrossian J, Bitker MO, Hiesse C, Lang P. Diabetes mellitus after renal transplantation: Characteristics, outcome, and risk factors. Transplant 1996; 61: 14751478.DOI: 10.1097/00007890-199605270-00011
  • 16
    Al Uzri A, Stablein DM, Cohn A. Posttransplant diabetes mellitus in pediatric renal transplant recipients: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplant 2001; 72: 10201024.DOI: 10.1097/00007890-200109270-00007
  • 17
    Yoshimura N, Nakai I, Ohmori Y et al. Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 1988; 12: 1117.
  • 18
    Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS, FK506 Kidney Transplant Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplant 1997; 63: 977983.DOI: 10.1097/00007890-199704150-00013
  • 19
    Meltzer S, Leiter L, Daneman D et al. 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ 1998; 159 (Suppl 8): S129.
  • 20
    Puavilai G, Chanprasertyotin S, Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract 1999; 44: 2126.DOI: 10.1016/S0168-8227(99)00008-X
  • 21
    Mayer AD, Dmitrewski J, Squifflet JP et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group. Transplant 1997; 64: 436443.DOI: 10.1097/00007890-199708150-00012
  • 22
    Hricik DE, Anton HA, Knauss TC et al. Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. Transplant 2002; 74: 189193.DOI: 10.1097/00007890-200207270-00008
  • 23
    Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002; 13: 13741380.
  • 24
    Konrad T, Vicini P, Zeuzem S et al. Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease. Exp Clin Endocrinol Diabetes 1999; 107: 343349.
  • 25
    Baid S, Cosimi AB, Farrell ML et al. Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplant 2001; 72: 10661072.
  • 26
    Vanrenterghem Y, Lebranchu Y, Hene R, Oppenheimer F, Ekberg H. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplant 2000; 70: 13521359.DOI: 10.1097/00007890-200011150-00015
  • 27
    Sumrani NB, Delaney V, Ding ZK et al. Diabetes mellitus after renal transplantation in the cyclosporine era–an analysis of risk factors. Transplant 1991; 51: 343347.
  • 28
    Miles AM, Sumrani N, Horowitz R et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplant 1998; 65: 380384.DOI: 10.1097/00007890-199802150-00014